Literature DB >> 17102545

Current understanding of the molecular basis of chloroquine-resistance in Plasmodium falciparum.

H Jiang1, D A Joy, T Furuya, X-z Su.   

Abstract

Chloroquine (CQ) is the most successful antimalarial drug ever discovered. Unfortunately, parasites resistant to the drug eventually emerged after its large scale use and are now widespread. Although great progress in our understanding of the mechanisms of CQ action and CQ resistance (CQR) has been achieved over the past two decades, including the identification of the molecules responsible for CQR (e.g., Plasmodium falciparum chloroquine resistant transporter, PfCRT) many questions remain unanswered. Here we highlight recent advances in our understanding of the genetics and molecular mechanisms of CQR, with particular emphasis on the role of genes such as pfcrt and pfmdr1 in the resistance to CQ and other drugs. New drug development and applications will undoubtedly benefit from a better understanding of CQR, eventually leading to more effective malaria control measures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102545

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  8 in total

Review 1.  Drug resistance and genetic mapping in Plasmodium falciparum.

Authors:  Karen Hayton; Xin-Zhuan Su
Journal:  Curr Genet       Date:  2008-09-18       Impact factor: 3.886

2.  Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.

Authors:  Christian Supan; Ghyslain Mombo-Ngoma; Matthias P Dal-Bianco; Carmen L Ospina Salazar; Saadou Issifou; Florent Mazuir; Aziz Filali-Ansary; Christophe Biot; Daniel Ter-Minassian; Michael Ramharter; Peter G Kremsner; Bertrand Lell
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

3.  Transcriptomic profiling of the Saccharomyces cerevisiae response to quinine reveals a glucose limitation response attributable to drug-induced inhibition of glucose uptake.

Authors:  Sandra C dos Santos; Sandra Tenreiro; Margarida Palma; Jorg Becker; Isabel Sá-Correia
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

4.  Evaluation of allelic forms of the erythrocyte binding antigen 175 (EBA-175) in Plasmodium falciparum field isolates from Brazilian endemic area.

Authors:  Daiana S Perce-da-Silva; Dalma M Banic; Josué C Lima-Junior; Fátima Santos; Cláudio T Daniel-Ribeiro; Joseli de Oliveira-Ferreira; Lilian R Pratt-Riccio
Journal:  Malar J       Date:  2011-05-26       Impact factor: 2.979

5.  Use of high-density tiling microarrays to identify mutations globally and elucidate mechanisms of drug resistance in Plasmodium falciparum.

Authors:  Neekesh V Dharia; Amar Bir Singh Sidhu; María Belén Cassera; Scott J Westenberger; Selina Er Bopp; Rich T Eastman; David Plouffe; Serge Batalov; Daniel J Park; Sarah K Volkman; Dyann F Wirth; Yingyao Zhou; David A Fidock; Elizabeth A Winzeler
Journal:  Genome Biol       Date:  2009-02-13       Impact factor: 13.583

Review 6.  Genetics of chloroquine-resistant malaria: a haplotypic view.

Authors:  Gauri Awasthi; Aparup Das
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-12       Impact factor: 2.743

7.  Antiplasmodial Cyclodecapeptides from Tyrothricin Share a Target with Chloroquine.

Authors:  Adrienne N-N Leussa; Marina Rautenbach
Journal:  Antibiotics (Basel)       Date:  2022-06-14

Review 8.  Recent advances in the discovery of haem-targeting drugs for malaria and schistosomiasis.

Authors:  Katherine A de Villiers; Timothy J Egan
Journal:  Molecules       Date:  2009-08-04       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.